European Journal of Cardiovascular Medicine

Background- The purpose of this study was to assess the effectiveness of oncoplastic surgical management for benign phyllodes tumour. Methods- Patients (n = 37) with eligible breast benign phyllodes tumour underwent oncoplastic surgical management. Primary outcome measures included, postoperative recurrence, and intra-operative and postoperative complications. Results-Thirty-seven patients who underwent surgical excision and oncoplastic breast surgery. The age range of the patients was 42 to 58 years. The majority of breast lesions were between 5 and 10 cm in size, ranging in size from 3.5 to 12.5 cm. On the seventh post-operative day, 56.8% of patients reported pain at the surgical site, 10.8% of patients had seroma, 5.4% had wound infections, 5.4% had flap necrosis, and 21.6% had lymphedema. Pain observed On Day 7 (56.8% of patients), there were 21 patients; on Day 21, there were 5 patients (13.5% of patients). There was a statistically significant difference in the proportion (P=0.001). Conclusions-Surgery and oncoplastic breast surgery are safe and effective for benign phyllodes tumours. Oncoplastic breast conservation surgery allows greater parenchymal resection without compromising oncology or aesthetics. Histopathological analysis pre-operatively reduces recurrences, reoperations, and oncologic outcomes. It can also prevent adjuvant therapy delays.